From the Chief
"I am eager to come to work every day, because this is where groundbreaking discoveries and cures will come from."
News & Media
Dr. Lawrence Brandt Receives Lifetime Achievement Award
Dr. Lawrence J. Brandt is the recipient of the Peggy Lillis Foundation's Lifetime Achievement Award.
Allan Wolkoff Named American Liver Foundation Physician of the Year
Dr. Allan W. Wolkoff has been invited to receive the 2015 American Liver Foundation Physician of the Year Award for an extraordinary record of service including long-term leadership as a member of the Board of Directors and past chair.
Research Skills for Clinicians
Dr. Lawrence Brandt was featured for his participation in the Einstein Clinical Research Training Program (CRTP), which offers a Master of Science in Clinical Research Methods.
GI & Liver Diseases Announces Specialized IBD Program
The Einstein Division of Gastroenterology & Liver Diseases proudly announces its Program for Inflammatory Bowel Diseases, an innovative, multidisciplinary treatment initiative offering comprehensive medical and surgical care for patients with inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
Dr. Namita Roy-Chowdhury Honored With Mahatma Gandhi Overseas Indian Award
Dr. Namita Roy-Chowdhury was conferred the 2014 Mahatma Gandhi Award/Pravasi Bharatiya Samman Award (PBSA), the highest honor bestowed on overseas Indians.
GI & Liver Diseases Faculty Well Represented at AASLD 2014 Meeting
Gastroenterology & Liver Diseases faculty were well represented at the 65th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 2014 in Boston, MA.
Five GI & Liver Diseases Faculty Members Named AASLD Fellows
Drs. Mark Czaja, Paul Gaglio, Sanjeev Gupta, Jayanta Roy-Chowdhury, and Allan Wolkoff have been selected for the 2014 Inaugural Class of American Association for the Study of Liver Diseases Fellows.
GI & Liver Diseases Faculty Well Represented at ACG 2014
The Division of GI & Liver Diseases was well represented at the 2014 American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course in Philadelphia, with lectures, presentations, and hands-on training sessions by Drs. David Greenwald and Lawrence Brandt, and award-winning posters by Drs. T.S. Dharmarajan and Annu Gupta.
Why Hepatitis C Is Vastly Underreported
Hepatitis C virus (HCV) continues to be the number one cause of cirrhosis and liver cancer and the primary indicator for liver transplantation in the United States, yet it remains vastly underdiagnosed. Why is HCV underreported?
Dr. David Greenwald Delivers Capitol Hill Colonoscopy Briefing
Dr. David Greenwald recently joined a group of distinguished gastroenterologists for a Capitol Hill briefing to to highlight the potential of colonoscopy to save lives.
Dr. David Greenwald Receives ACG Award
Dr. David Greenwald recently received the William Carey Award at the annual meeting of the American College of Gastroenterology (ACG).
Transplant Changes Marlborough Woman's Life
Dr. Lawrence Brandt commented on his patient Shirley Fogge Piazza’s successful fecal transplant.
Cuervo Leads Panels at NIH Aging and Chronic Disease Symposium on Geroscience
The NIH has chosen Drs. Ana Maria Cuervo and Jeffrey Pessin to chair panels at the first symposium on "geroscience"—the study of how aging influences the onset of chronic diseases.
Zheng Receives Emerging Liver Scholar Resident Travel Award
Mentored by Dr. Allan Wolkoff, third-year resident Elizabeth Zheng was awarded an American Association of Liver Diseases (AASLD) Emerging Liver Scholar Resident Travel Award.
Scientists Identify 'Clean-Up' Snafu that Kills Brain Cells in Parkinson's Disease
Dr. Ana Maria Cuervo has discovered why toxic clumps of proteins accumulate in brain cells of those with a familial form of Parkinson's disease.
Nature interviewed Lawrence Brandt, M.D., about the first randomized clinical trial on using fecal transplants to treat recurring infections of Clostridium difficile, a bacterium that causes severe diarrhea. While the standard antibiotic treatment cured 27% of patients in the trial, fecal transplants cured 94%. Dr. Brandt, professor of medicine and of surgery at Einstein and emeritus chief of gastroenterology at Montefiore Medical Center, leads a blinded trial in which patients are treated with their own feces or those from healthy donors. (Thursday, January 17, 2013)
More coverage on this story
The New York Times
Los Angeles Times
Wolkoff Receives Distinguished Scientific Achievement Award
Dr. Allan Wolkoff, Chief of the Division of Gastroenterology and Liver Diseases at Einstein and Montefiore, and Professor of Medicine and Anatomy & Structural Biology at Einstein, received the 2012 Distinguished Scientific Achievement Award from the American Liver Foundation. This award is among the Foundation’s most prestigious honors and recognizes a scientist who has made a major contribution to the study of liver pathobiology and the prevention, treatment, or cure of liver disease.
Einstein On: Liver Disease, Dr. Allan Wolkoff
Allan W. Wolkoff, M.D., discusses liver disease and current research that could ultimately lead to new treatments.
The Washington Post quotes Dr. Lawrence Brandt regarding new guidelines for managing irritable bowel syndrome (IBS). Dr. Brandt is professor of medicine and of surgery at Einstein, and chief of gastroenterology at Montefiore Medical Center. (Thursday, December 18, 2008) read more...
An abstract co-authored by Dr. Lawrence Brandt and chief resident Dr. Olga Aroniadis (Gastroenterology & Liver Diseases) and submitted for presentation to the American College of Gastroenterology at its annual meeting won one of the five Governors' Awards for Excellence in Clinical Research. The abstract will be presented at the plenary session during the meeting in late October. Mellow, M, Kanatzar A, Brandt L , Aroniadis O, Kelly C, Stollman N, Rohlke F, Surawicz, C. Longterm Follow up of Colonoscopic Fecal Bacteriotherapy for Recurrent C. difficile Infection.
Dr. Paul Gaglio (Gastroenterology & Liver Diseases) was honored by the American Liver Foundation Greater New York Division on September 27th at its annual gala. Founded in 1997, the American Liver Foundation Greater New York Division serves New York State and Northeastern New Jersey, providing services including support groups, liver wellness education programs, a national helpline, fundraising events, and volunteer opportunities. The Division has successfully served thousands of liver disease patients and their families. See the American Liver Foundation website for more information.